Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01277250 · ClinicalTrials.gov registry record · Phase 4
Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient
A Phase 4 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 4
- Development phase
- 1,548
- Enrollment target
NCT01277250: Completed Phase 4 study, sponsored by University of Alabama at Birmingham.
NCT01277250 is a Phase 4 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1,548 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (199% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01277250, a Phase 4 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1,548 participants
- Enrollment target
Study Summary
This project, "Web-based Smoking Cessation Intervention: transition from inpatient to outpatient," addresses smoking among hospitalized patients, whose rates are higher than among the general population. Hospitalization offers a unique opportunity to intervene, as it requires temporary abstinence and patients are focused on health concerns. Hypotheses: A tailored web-based and e-message smoking cessation program for current smokers that, upon hospital discharge, transitions the patient to continue a quit attempt when home will be effective. Further, the investigators hypothesize that this approach will be cost-effective. Specific Aims: 1. To test the effectiveness of a web-based smoking cessation intervention. 2. To determine the cost-effectiveness of this approach. Research Design - Methods: A randomized two-arm follow-up design will be used to test the effectiveness of an evidence- and theoretically-based smoking cessation program designed for post-hospitalization. Patients randomized to this arm will be contacted by hospital staff, trained as 'transition coaches,' to engage in Decide2Quit, an interactive web-based program that offers personalized and tailored messages, e-group support, and text messages promoting tobacco abstinence. All hospitalized patients will receive standardized smoking cessation materials. As well, physicians can order nicotine replacement therapy via the hospital's electronic order system. The investigators primary outcome is biologically confirmed and self-reported tobacco abstinence at 6 months follow-up; the investigators will also assess self-reported quit rates at 3 and 12 months and variables hypothesized to predict quit success. We will measure health care utilization and quality of life to allow testing the cost-effectiveness of this program conducted from the perspective of a hospital, health care payers, patients and society. Significance of results: At study completion the investigators will know whether imbedding smoking cessat
Primary Outcome
Biochemically-verified (cotinine) and self-reported tobacco abstinence
Interventions
- BEHAVIORAL Web-based smoking cessation program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,548 participants |
| Start Date | 2011-07 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
What the finished NCT01277250 record still lists
NCT01277250 is an interventional study that assigns participants to a tested intervention. Its 1,548 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (199% higher).
The record links to 0 conditions, and to 1 intervention - of which Web-based smoking cessation program is the first listed.
NCT01277250 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01277250 about?
NCT01277250 is a clinical study titled "Web-based Smoking Cessation Intervention: Transition From Inpatient to Outpatient". This project, "Web-based Smoking Cessation Intervention: transition from inpatient to outpatient," addresses smoking among hospitalized patients, whose rates are higher than among the general population. Hospitalization offers a unique opportunity to intervene, as it requires temporary abstinence an...
What is the current status of trial NCT01277250?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 1,548 participants. The study started on 2011-07. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01277250?
The interventions under investigation include: Web-based smoking cessation program (BEHAVIORAL).
Who is sponsoring clinical trial NCT01277250?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01277250's enrollment target sits among peer trials
1,548 50th of 2000 higher than 1,951 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02650622 · 1,550 participants
Genetic and Metabolic Disease in Children
- NCT03961945 · 1,550 participants · NA
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
- NCT06729775 · 1,546 participants · NA
Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back
- NCT03435796 · 1,541 participants · Phase 2
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia